Ewes were synchronized for estrus using the OvSynch protocol and a dose of LC (20 mg/kg body weight) was intravenously (IV) administered on the same day of PGF 2 injection to one group (n = 8
The investment bank flagged potential pricing pressure, rising competition in the obesity drug market and the possibility that long-term revenue expectations for GLP-1 drugs may be overly optimistic
TrimRx is becoming a popular choice for individuals who want a modern, medically guided approach to weight loss
Once the medication stops, old eating habits often resurface because the environmental triggers and food-related cues have not disappeared
Over 68 weeks, those in the semaglutide group lost an average of 14.9 percent of their baseline body weight, versus just 2.4 percent in the control group, with the treatment effect yielding a 12.4 percent greater reduction in body weight compared to placebo
The expanding role of these drugs in cardiovascular risk reduction and renal protection also positions them as valuable interventions beyond glucose control
